MRRGX
Price
$34.42
Change
-$0.60 (-1.71%)
Updated
Sep 12 closing price
Net Assets
722.76M
WCMNX
Price
$13.48
Change
-$0.22 (-1.61%)
Updated
Sep 12 closing price
Net Assets
44.71M
Interact to see
Advertisement

MRRGX vs WCMNX

Header iconMRRGX vs WCMNX Comparison
Open Charts MRRGX vs WCMNXBanner chart's image
Meridian Growth Institutional
Price$34.42
Change-$0.60 (-1.71%)
VolumeN/A
Net Assets722.76M
WCM Small Cap Growth Investor
Price$13.48
Change-$0.22 (-1.61%)
VolumeN/A
Net Assets44.71M
MRRGX vs WCMNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MRRGX vs. WCMNX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRRGX is a Hold and WCMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MRRGX has more cash in the bank: 723M vs. WCMNX (44.7M). MRRGX (0.00) and WCMNX (0.00) have matching dividends . MRRGX was incepted earlier than WCMNX: MRRGX (11 years) vs WCMNX (6 years). WCMNX (2.04) is less costly to investors than MRRGX (0.88). WCMNX is a more actively managed with annual turnover of: 83.00 vs. MRRGX (33.00). WCMNX has a lower initial minimum investment than MRRGX: WCMNX (1000) vs MRRGX (1000000). WCMNX annual gain was more profitable for investors over the last year : 7.41 vs. MRRGX (-3.10). WCMNX return over 5 years is better than : 22.77 vs. MRRGX (-9.01).
MRRGXWCMNXMRRGX / WCMNX
Total Expense Ratio0.881.2471%
Annual Report Gross Expense Ratio0.882.0443%
Fund Existence11 years6 years-
Gain YTD-5.3886.225-87%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets723M44.7M1,617%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.107.41-42%
Returns for 3 years-4.6023.78-19%
Returns for 5 years-9.0122.77-40%
Returns for 10 years-2.41N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWBO0.260.01
+3.51%
Northwest Biotherapeutics, Inc.
ANSLY90.19N/A
N/A
Ansell Ltd.
HCBN36.75N/A
N/A
H.C.B. Financial Corp.
LFABF36.00N/A
N/A
Lifco AB
SPTY0.11-0.05
-30.04%
Specificity, Inc.